Polyfunctional response by ImmTAC (IMCgp100) redirected CD8(+) and CD4(+) T cells

The success of immune system‐based cancer therapies depends on a broad immune response engaging a range of effector cells and mechanisms. Immune mobilizing monoclonal T cell receptors (TCRs) against cancer (ImmTAC™ molecules: fusion proteins consisting of a soluble, affinity enhanced TCR and an anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Boudousquie, Caroline, Bossi, Giovanna, Hurst, Jacob M., Rygiel, Karolina A., Jakobsen, Bent K., Hassan, Namir J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629433/
https://www.ncbi.nlm.nih.gov/pubmed/28640942
http://dx.doi.org/10.1111/imm.12779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629433/
https://www.ncbi.nlm.nih.gov/pubmed/28640942
http://dx.doi.org/10.1111/imm.12779

Ejemplares similares